BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of lung cancer.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

The WHO's draft agreement, to be approved in May, emphasizes international coordination to improve pandemic preparedness.

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

Inappropriate Medicare imaging examinations may have produced as many tons of carbon dioxide equivalents as a town of 72,000 people annually.

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Experts expect the NIH funding freeze to reduce new drug development and impede scientists' growth across American research facilities.

Patients with PWS admitted to the hospital with COVID-19 showed increased risk of in-hospital mortality, severe disease, and mechanical ventilation.

The FDA will now allow review staff and supervisors to work remotely at least twice weekly after a recent return to office order.

The FDA is favoring newer testing and modeling methods that reduce animal testing, research costs, and evaluation time.

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.